Guardant Health Inc [GH] stock is trading at $105.42, up 5.10%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GH shares have gain 11.71% over the last week, with a monthly amount glided 52.01%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on September 25, 2025, when Wolfe Research upgraded its rating to an Outperform but kept the price target unchanged to $75 for it. On April 10, 2025, Mizuho initiated with an Outperform rating and assigned a price target of $55 on the stock. Barclays started tracking the stock assigning an Overweight rating and suggested a price target of $60 on January 23, 2025. Guggenheim upgraded its rating to a Buy but $36 remained the price target by the analyst firm on June 28, 2024.
Guardant Health Inc [GH] stock has fluctuated between $29.91 and $110.00 over the past year. Currently, Wall Street analysts expect the stock to reach $88.89 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $105.42 at the most recent close of the market. An investor can expect a potential drop of -15.68% based on the average GH price forecast.
Analyzing the GH fundamentals
Guardant Health Inc [NASDAQ:GH] reported sales of 902.57M for the trailing twelve months, which represents a growth of 38.50%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.49%, Pretax Profit Margin comes in at -0.44%, and Net Profit Margin reading is -0.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 1.52 and Total Capital is -0.43. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-3.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 99.75 points at the first support level, and at 94.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 109.58, and for the 2nd resistance point, it is at 113.73.
Ratios To Look Out For
For context, Guardant Health Inc’s Current Ratio is 3.50. In addition, the Quick Ratio stands at 3.12 and the Cash Ratio stands at 2.45. Considering the valuation of this stock, the price to sales ratio is 15.11.
Transactions by insiders
Recent insider trading involved Tariq Musa, Director, that happened on Nov 19 ’25 when 116.0 shares were sold. Director, Tariq Musa completed a deal on Nov 19 ’25 to buy 116.0 shares. Meanwhile, Director Hidalgo Medina Manuel sold 1500.0 shares on Nov 07 ’25.
